The Clorox Company (CLX)

Return on sales

The profitability ratios of The Clorox Company over the analyzed period reflect a nuanced financial performance characterized by both improvement and fluctuation across different measures.

Gross Profit Margin:
The gross profit margin exhibits an overall increasing trend from a low of 35.52% at the end of September 2022 to a peak of approximately 45.13% projected for March 2025. This upward trajectory suggests enhanced efficiency in managing cost of goods sold (COGS) relative to revenue, potentially driven by product mix shifts, cost control initiatives, or economies of scale.

Operating Profit Margin:
The operating margin demonstrates variability with a notable declining phase from over 20% in late 2020 to around 7.97% in December 2022, subsequently recovering to approximately 20.44% by the end of 2023. For the latest quarters, the margin stabilizes around 18-19%. The overall pattern indicates periods of margin compression, possibly related to increased operating expenses or competitive pressures, followed by recovery, signaling operational adjustments or improvements in operational leverage.

Pretax Margin:
The pretax margin shows a decreasing trend from highs above 20% in 2020 towards lows below 5% in late 2021 and early 2022, followed by a gradual recovery to nearly 13.43% projected by March 2025. These fluctuations may reflect changes in non-operating income, interest expense, or tax obligations, influencing pre-tax profitability beyond core operations.

Net Profit Margin:
Similarly, the net profit margin declines sharply from approximately 16% in 2020 to below 2% in 2021, often dipping into the single-digit range, with recent data indicating improvement toward nearly 10% by March 2025. This pattern underscores periods of diminished bottom-line profitability, potentially affected by increased costs, restructuring charges, or external economic factors, followed by a recovery phase suggesting effective cost management or revenue growth initiatives.

Summary:
Overall, The Clorox Company experienced a decline in profitability ratios through 2021 and 2022, driven by margin compression at various levels, before showing signs of recovery in subsequent periods. The consistent upward trend in gross profit margin suggests better control over production costs, while the recovery in operating and net margins indicates operational and strategic adjustments to improve overall profitability. Continuous monitoring of these ratios will be essential to assess sustained profitability and operational efficiency.

---

Return on investment

The profitability ratios for The Clorox Company over the specified period exhibit notable fluctuations, reflecting the company's operational performance and efficiency in generating earnings relative to its assets and capital.

Operating Return on Assets (Operating ROA):
The operating ROA demonstrates an increasing trend from June 2020, rising from 20.30% to a peak of 25.29% by December 2023. This upward trajectory indicates improved efficiency in utilizing operating assets to generate operating income during this period. After reaching the peak, the ratio declines slightly to 21.95% in March 2024 before recovering marginally to 23.49% in March 2025. The overall trend suggests a period of operational strengthening interspersed with minor fluctuations, possibly impacted by market conditions or strategic initiatives.

Return on Assets (ROA):
The ROA for the company starts at 15.11% in June 2020 and exhibits a general declining trend during 2020 and 2021, reaching a low of approximately 1.39% in December 2023. Subsequently, the ratio shows signs of recovery, standing at 12.59% in March 2025. The significant decline in ROA during 2021 and mid-2022 reflects a period of reduced net income relative to total assets, potentially influenced by increased expenses, asset base growth, or external factors affecting net profitability. The partial recovery post-2023 indicates some resumption of profitability efficiency.

Return on Total Capital (ROTC):
ROTC ratios are exceptionally high, illustrating the company's effective use of capital to generate returns. Throughout 2020 and 2021, the ratios fluctuate but remain notably elevated, with values often exceeding 100%, peaking at over 8,000% in March 2023. This extraordinary figure suggests either accounting anomalies, leverage effects, or extraordinary income components significantly boosting return metrics. After the peak, ROTC ratios decrease substantially, but remain significantly above historical levels, indicating ongoing high relative returns. Notably, the ratios in late 2024 and early 2025 show renewed elevation, exceeding 1,000%, which again points to unusual accounting influences or exceptional income.

Return on Equity (ROE):
ROE metrics demonstrate considerable variability, with values generally high, reflecting the company's effective equity utilization. From around 103% in 2020, ROE peaks dramatically at 2,533.33% in March 2023, suggesting extraordinary gains or leverage effects. Subsequent periods reveal fluctuations, with ratios dropping to more moderate levels like 154.72% in December 2023 and rising again sharply to over 2,500% by March 2025. The extreme figures during certain periods imply the impact of one-time items, leverage, or accounting distortions rather than purely operational profitability.

Summary:
Overall, the company's profitability ratios reveal a pattern of improving operational efficiency until late 2023, followed by periods of volatility likely influenced by extraordinary income, leverage, or accounting adjustments. The ratios suggest that while The Clorox Company generally maintains strong profitability metrics, certain peaks and troughs are indicative of extraordinary factors rather than consistent operational performance alone. The anomalies in these ratios warrant further investigation into underlying accounting practices and non-recurring income components affecting these ratios disproportionately.